Expert Testimony Litigation Pharmaceuticals 
IP Watchdog
JUNE 21, 2022
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Earlier today, the U.S. Accord Healthcare, Inc. granting a petition for rehearing from appellant HEC Pharm Co.,
CaseFox
NOVEMBER 27, 2023
Over time, legal frameworks developed to address these concerns, forming the foundation for contemporary exposure litigation. High-profile incidents, such as Love Canal and asbestos-related diseases, prompted regulatory changes and a surge in environmental and occupational health litigation.
Practice of Law
OCTOBER 15, 2024
All of these are major pharmaceutical companies with extensive histories and significant roles in the development, manufacturing, and distribution of medications – and one in particular: ranitidine. There, plaintiffs were allowed to present expert testimony on the cancer link. You might recognize it better as Zantac.
Expert insights. Personalized for you.
59 
Let's personalize your content